BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27403030)

  • 1. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
    Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
    Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in liver cancer.
    Labgaa I; Villanueva A
    Discov Med; 2015 Apr; 19(105):263-73. PubMed ID: 25977189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
    Cai ZX; Chen G; Zeng YY; Dong XQ; Lin MJ; Huang XH; Zhang D; Liu XL; Liu JF
    Int J Cancer; 2017 Sep; 141(5):977-985. PubMed ID: 28543104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.
    Tsujiura M; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    World J Gastroenterol; 2014 Mar; 20(12):3265-86. PubMed ID: 24696609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma.
    Zhou J; Shi YH; Fan J
    Semin Oncol; 2012 Aug; 39(4):440-8. PubMed ID: 22846861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation.
    Sánchez-Lorencio MI; Ramirez P; Saenz L; Martínez Sánchez MV; De La Orden V; Mediero-Valeros B; Veganzones-De-Castro S; Baroja-Mazo A; Revilla Nuin B; Gonzalez MR; Cascales-Campos PA; Noguera-Velasco JA; Minguela A; Díaz-Rubio E; Pons JA; Parrilla P
    Transplant Proc; 2015 Nov; 47(9):2639-42. PubMed ID: 26680058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
    Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma.
    Nel I; Baba HA; Weber F; Sitek B; Eisenacher M; Meyer HE; Schlaak JF; Hoffmann AC
    Biomark Med; 2014; 8(5):687-98. PubMed ID: 25123037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.